Señales en vivo de PDSB | Maximiza tus Ganancias con Getagraph.com

VENDER 118430 min ago

@ $5.26

Emitido: 14 feb 2024 @ 12:24

Retorno: -29.09%

Señal anterior: feb 12 - 12:29

Señal anterior: Comprar

Retorno: -3.66 %

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 16:00):

Stats
Volumen de hoy	709 978
Volumen promedio	916 911
Capitalización de mercado	136.81M
EPS	$0 ( 2024-03-27 )
Próxima fecha de ganancias	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.68
ATR14	$0.00900 (0.24%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Toutain Stephan	Buy	200 000	Employee Stock Option (Right to Buy)
2024-05-01	Toutain Stephan	Buy	0
2024-01-22	Shepard Kirk V.	Buy	200 000	Employee Stock Option (Right to Buy)
2024-01-22	Shepard Kirk V.	Buy	0
2023-12-04	Boesgaard Lars	Buy	200 000	Employee Stock Option (Right to Buy)

INSIDER POWER
77.12
Last 92 transactions
Buy: 4 991 106 \| Sell: 920 084

Volumen Correlación

Largo: -0.39 (neutral)

Corto: 0.79 (moderate)

Signal:(19.776) Neutral

PDS Biotechnology Corp Correlación

10 Correlaciones Más Positivas
BRZE	0.889
TBBK	0.884
LUNA	0.878
EA	0.876
AMRS	0.875
AZ	0.873
DMRC	0.868
PRFT	0.868
LIAN	0.863
BCEL	0.858

10 Correlaciones Más Negativas
SIEB	-0.91
CTIC	-0.9
RILYM	-0.898
PPTA	-0.879
CURI	-0.879
LWAY	-0.874
SCTL	-0.873
CDXC	-0.873
TIGO	-0.872
SIGA	-0.872

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PDS Biotechnology Corp Correlación - Moneda/Commodity

0.35
( neutral )

0.11
( neutral )

0.00
( neutral )

0.27
( neutral )

0.00
( neutral )

-0.37
( neutral )

PDS Biotechnology Corp Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-57 326.00 (0.00 %)
EPS:	$-1.390

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-57 326.00 (0.00 %)
EPS:	$-1.390

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-49 078.00 (0.00 %)
EPS:	$-1.430

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.660

Financial Reports:

No articles found.

PDS Biotechnology Corp

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.